We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MBI market cap is 776.57k. The company's latest EPS is USD -0.0034 and P/E is -2.94.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -63k | -54k | -60k | -63k | -58k |
| Net Income | -63k | -54k | -60k | -63k | -58k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13k | 82k | 11k | 3k | 2k |
| Total Liabilities | 50k | 178k | 92k | 69k | 129k |
| Total Equity | -37k | -96k | -81k | -66k | -127k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -151k | 72k | -145k | -8k | 3k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 164k | N/A | 75k | -3k | N/A |
| Market Cap | 776.57k |
| Price to Earnings Ratio | -2.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 100 |
| Price to Book Ratio | -1.36 |
| Dividend Yield | - |
| Shares Outstanding | 17.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (30.77%) |
| Company Name | Med Biogene Inc |
| Address |
598 east kent avenue south, vancouver vancouver, british columbia V5X 4V6 |
| Website | https://www.medbiogene.com/en/406/index.html |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
